Pathway Analysis for Basal Cell Carcinoma Risk
Author Information
Author(s): Zhang Mingfeng, Liang Liming, Xu Mousheng, Qureshi Abrar A., Han Jiali
Primary Institution: Brigham and Women's Hospital, Harvard Medical School
Hypothesis
Can a pathway-based approach identify genetic pathways associated with basal cell carcinoma (BCC) risk?
Conclusion
The study identified four pathways associated with BCC risk, suggesting new insights into its etiology.
Supporting Evidence
- The heparan sulfate biosynthesis pathway was significantly associated with BCC risk (p = 0.007).
- The mCalpain pathway showed a significant association with BCC risk (p = 0.002).
- The Rho cell motility signaling pathway was significantly associated with BCC risk (p = 0.011).
- The nitric oxide pathway was significantly associated with BCC risk (p = 0.022).
Takeaway
Researchers looked at how certain groups of genes might be linked to skin cancer, and they found some important pathways that could help us understand why some people get it.
Methodology
The study involved a genome-wide association study (GWAS) with 1,797 BCC cases and 5,197 controls, analyzing SNPs and their association with BCC risk using pathway analysis.
Potential Biases
Potential bias from the case-control status of type 2 diabetes and coronary heart disease was considered.
Limitations
The study's pathway definitions may not comprehensively represent all functionally related genes, and the sample size may limit the robustness of the findings.
Participant Demographics
All participants were of European ancestry and lived in the United States.
Statistical Information
P-Value
0.002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website